## EQT: EQT Corporation - XLE: Energy

### Executive Summary

VALUE thesis: PEG 0.48 indicates fundamental undervaluation. Consistent execution (4/4 quarters beat estimates).

- **Horizon:** 20-60 days (position)
- **Risk Profile:** Lower - fundamental undervaluation
- **Stop Type:** Fixed 2xATR ($51.55)
- **If Wrong:** Exit if fundamentals deteriorate or stop hit
- **Invalidation:** PEG > 1.5 or earnings miss

### News

- **Articles:** 2
- **Sentiment:** Neutral (Bullish: 0, Bearish: 0)

**1. Siebert Williams Shank & Co Sticks to Their Hold Rating for EQT (EQT)**
- Source: The Globe and Mail | 20251230T130846 | Neutral | Relevance: 100%
- Siebert Williams Shank & Co analyst Gabriele Sorbara maintained a Hold rating on EQT with a $62.00 price target. This comes as corporate insider sentiment for EQT is negative, with increased insider selling activity in the past quarter, alongside recent mixed analyst ratings. The company recently reported strong quarterly revenue and net profit figures.

**2. Siebert Williams Shank & Co Keeps Their Hold Rating on CNX Resources (CNX)**
- Source: The Globe and Mail | 20251230T180846 | Neutral | Relevance: 63%
- Siebert Williams Shank & Co analyst Gabriele Sorbara maintained a Hold rating on CNX Resources (CNX) with a price target of $36.00. This comes as CNX Resources reported strong quarterly revenues of $583.84 million and a net profit of $202.1 million for the quarter ending September 30. Other firms, such as Piper Sandler, have issued a Sell rating for CNX Resources.

### Analyst Activity

**Target Signal:** BULLISH (Raises: 2, Lowers: 1)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-19 | Citigroup | $62 | $63 | -2% |
| 2025-12-12 | UBS | $76 | $67 | +13% |
| 2025-12-12 | Mizuho | $68 | $60 | +13% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-19 | Citigroup | main | Buy |
| 2025-12-12 | UBS | main | Buy |
| 2025-12-12 | Mizuho | main | Outperform |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_SELLING** |
| Buys | 0 ($0.00M) |
| Sells | 2 ($3.56M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 49.1% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 7 / 3 |

**Top Holders:**
- Vanguard Group Inc: 12.7% (+6.2%)
- Blackrock Inc.: 7.7% (+1.1%)
- Wellington Managemen: 6.8% (-1.4%)
- State Street Corpora: 5.4% (+3.4%)
- Morgan Stanley: 3.8% (+12.3%)

### Key Risks

1. Insider selling cluster: $3.6M in recent transactions.
2. Market regime shift could impact momentum names disproportionately.
3. Sector rotation risk if leadership changes from current market theme.

### Catalysts

- Broader market risk-on sentiment could lift quality names.
- Year-end positioning and window dressing may support price.

### Fundamentals

PEG ratio 0.48 indicates undervaluation relative to growth. Forward P/E 12.4x attractive for 51% earnings growth. Quality metrics strong (margin 23%). Analyst sentiment positive (2 raises, avg +13%). Insider selling cluster ($3.6M in 90 days), potential headwind. Institutional flow bullish (7 buying vs 3 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $34.1B |
| Beta | 0.62 |
| 52W Range | $43.57 - $62.23 |
| Short Interest | 3.9% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 0.48 |
| Forward P/E | 12.4 |
| Current P/E | 18.8 |
| YoY Growth | 51.4% |
| EPS Direction | STABLE |

### Technicals

MRS_20 strengthening from -5.5% to -2.7% (+2.7% in 5 days), confirming momentum buildup. Below STRENGTH zone by 6.7pp (needs >4.0% for momentum thesis). MRS_5 turning positive (1.1%) - potential reversal signal. Underperforming sector by 3.1pp, stock-specific weakness. Long-term uptrend intact (above SMA200 at 1.01x) but short-term weakness (below SMA20). RSI neutral at 44. OFD pattern: -MTL (Decline).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_20 | -2.74% (CS: 16) | Weak |
| RSI_14 | 44.3 | Neutral |
| MACD Histogram | -0.15 | Bearish |
| vs SMA20 | 0.974x | Below |
| vs SMA50 | 0.967x | Below |
| vs SMA200 | 1.007x | Above |

### Decision

- **Verdict:** AVOID
- **Thesis:** VALUE

### Trade Setup

- **Entry:** $54.63
- **Stop Loss:** $51.55 (5.6% risk)
- **Target:** $60.79 (R:R method)
- **Risk/Reward:** 2.00:1
- **Target Reasoning:** VALUE thesis targets 2.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 357
- **Position Value:** $19,502.91
- **Portfolio %:** 19.50%
- **Risk Dollars:** $1,100.00
- **Risk Per Trade:** 1.10%
- **Modifiers:** L1 110% | L2 100% | Combined 1.10x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (HIGH) | 1.10x |
| L2 Sector | NEUTRAL (Zone E) | 1.00x |

*NORMAL regime with balanced risk signals and moderate market participation. VIX at 14.33 indicates calm conditions, while positive yield curve (+59bps) and stable economic data support continued expansion. Year-end positioning and Fed uncertainty create near-term caution, but no systemic risks evident.*

### Earnings

**Next:** 2026-02-17 (Est: $0.75)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $0.36 | $0.52 | +42.8% |
| 2025Q2 | $0.41 | $0.45 | +10.0% |
| 2025Q1 | $1.01 | $1.18 | +16.6% |
| 2024Q4 | $0.53 | $0.69 | +31.3% |

---
*RULE-based L3 | 2026-01-06 16:37 | MRS_20*